Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel synthesis route for pyrimidine intermediate offering mild conditions and simplified purification for scalable pharmaceutical manufacturing processes.
Advanced synthesis of 17-hydroxy-pregna-3,20-diketone intermediates via safe malonate addition. Reduces toxicity and improves supply chain reliability for steroid manufacturing.
Novel patent CN118834173A details dichloromethane as C1 source for 1 4 2 dioxazole synthesis offering green cost effective solutions for pharmaceutical intermediate manufacturing supply chains
Novel 5-step route from 3-picoline offers scalable, cost-effective production of high-purity 5-azaindole for kinase inhibitor APIs.
Patent CN103319399A details a green Hoffmann rearrangement route for R-3-aminopiperidine dihydrochloride, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Discover the scalable synthesis of 5-bromo oxoisoaporphine via patent CN103044326A. A robust route for high-purity pharmaceutical intermediates with significant antitumor potential.
Novel preparation method for Dasatinib intermediates offering high purity and yield. Reduces costs and improves supply chain reliability for pharmaceutical manufacturing partners.
Advanced HPLC purification method for vasopressin acetylated impurities using super water-resistant fillers. Reduces organic waste and ensures high purity for pharmaceutical quality control.
Novel oxidation method for Levofloxacin N Oxide ensures high purity and yield offering significant supply chain stability and cost advantages for pharmaceutical manufacturers.
Patent CN110407846B reveals a novel TMSCl-mediated nitration route for 5-ISMN. Achieve >99% purity and simplified supply chains for cardiovascular intermediates.
Novel patent CN116178386B reveals high-purity LE14 synthesis. Reduces impurities and costs for ADC manufacturing supply chains globally.
Patent CN110407846B introduces a mild, high-selectivity nitration method for 5-ISMN. Discover cost-effective, scalable pharma intermediate manufacturing solutions.
Patent CN111518131A details a novel high-yield synthesis for Orlistat intermediates, offering significant cost reduction and superior purity for pharmaceutical manufacturing supply chains.
Patent CN113912515A reveals a novel crystallization method for high-purity sartan biphenyl, offering significant cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Novel low-valent titanium route replaces Grignard. High purity 99.9%, scalable process for antihistamine API manufacturing.
Patent CN108440542B details asymmetric synthesis of spiro oxindoles. High purity and mild conditions offer cost reduction in pharmaceutical intermediate manufacturing.
Patent CN106589017B details a water-based synthesis for 3',4',7-trihydroxyethyl rutin. This method reduces waste and offers significant cost advantages for pharmaceutical intermediates manufacturing supply chains.
Novel solvent-based method for Glimepiride intermediate ensures high purity and safe commercial scale-up reducing genotoxic impurity risks for pharmaceutical supply chains globally
Discover the patented supercritical ammonia synthesis route for 6,6-dimethyl-3-azabicyclo[3.1.0]hexane. Enhance purity and reduce solvent costs for antiviral intermediates.
Advanced synthesis of Simeprevir intermediate via patent CN105348144B offers high purity and safer manufacturing for global pharmaceutical supply chains.